Randomized trial of olmesartan and azelnidipine for treatment of hypertension with chronic kidney disease
Not Applicable
- Conditions
- hypertension with CKD
- Registration Number
- JPRN-UMIN000006920
- Lead Sponsor
- Division of Nephrology, Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)secondary hypertension 2)patients who used to have side effects by ormesartan and/or azelnidipine 3)pregnacy 4)with steroid therapy 5)malignancy 6)severe liver disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method albuminuria blood pressure eGFR
- Secondary Outcome Measures
Name Time Method rinary angiotensinogen excresion serum ADMA